Literature DB >> 11856465

Microbial contamination of cord blood stem cells.

A Honohan1, H Olthuis, A T Bernards, J M van Beckhoven, A Brand.   

Abstract

BACKGROUND AND OBJECTIVES: After storage, low levels of contaminating bacteria in standard blood components can reach bacteraemic levels, causing severe transfusion-associated sepsis. For cord blood (CB), the significance of low levels of contaminating bacteria and the optimal detection method is unknown and not supported by available guidelines.
MATERIALS AND METHODS: Spiking experiments and testing of various subfractions of CB units were used to determine the behaviour of bacteria during centrifugation, freezing and thawing. For routine testing of CB, different volumes were compared for the detection of potential pathogens and micro-organisms of low pathogenicity.
RESULTS: Centrifugation, as applied to CB fractionation, does not show concentration of bacteria in any particular fraction and supports the possibility of culture of waste fractions. Dimethylsulphoxide (DMSO) and freezing does not affect the viability of bacteria under the conditions used in this study. Owing to the low contamination level, a large sample volume of 20 ml was more sensitive than a 10-ml sample volume. Eighty five per cent of the isolated strains can be considered to be of low pathogenicity.
CONCLUSION: When an optimal waste fraction sample volume of 20 ml was cultured, the contamination rate of CB was found to be approximately 13%, with low levels of < 1 colony-forming unit (CFU)/ml. Such levels of bacteria of low pathogenicity are expected to be of clinical importance only when CB is expanded in vitro for a prolonged period of time.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11856465     DOI: 10.1046/j.1423-0410.2002.00133.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  6 in total

1.  Comparison of the Bactec 9240 and BacT/Alert blood culture systems for evaluation of placental cord blood for transfusion in neonates.

Authors:  Stefan Riedel; Alan Junkins; Paul D Stamper; Gretchen Cress; John A Widness; Gary V Doern
Journal:  J Clin Microbiol       Date:  2009-04-15       Impact factor: 5.948

2.  Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Authors:  Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-10       Impact factor: 5.742

Review 3.  Is there a role for autologous/placental red blood cell transfusions in the anemia of prematurity?

Authors:  Ronald G Strauss; John A Widness
Journal:  Transfus Med Rev       Date:  2010-04

4.  The ratio of nicotinic acid to nicotinamide as a microbial biomarker for assessing cell therapy product sterility.

Authors:  Jiayi Huang; Liang Cui; Meenubharathi Natarajan; Paul W Barone; Jacqueline M Wolfrum; Yie Hou Lee; Scott A Rice; Stacy L Springs
Journal:  Mol Ther Methods Clin Dev       Date:  2022-04-13       Impact factor: 5.849

5.  Microbial Contaminants of Cord Blood Units Identified by 16S rRNA Sequencing and by API Test System, and Antibiotic Sensitivity Profiling.

Authors:  Luís França; Catarina Simões; Marco Taborda; Catarina Diogo; Milton S da Costa
Journal:  PLoS One       Date:  2015-10-29       Impact factor: 3.240

6.  Contamination Rate of Cryopreserved Umbilical Cord Blood Is Inversely Correlated with Volume of Sample Collected and Is also Dependent on Delivery Mode.

Authors:  Susanne Reuther; Kathrin Floegel; Gunther Ceusters; Veronica Albertini; Jakub Baran; Wolfram Dempke
Journal:  Stem Cells Transl Med       Date:  2022-06-22       Impact factor: 7.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.